Ex Parte SATO - Page 6




          Appeal No. 2000-0427                                                        
          Application No. 08/773,173                                                  

          arguments not made separately for any individual claim or claims            
          are considered waived.  See 37 CFR § 1.192 (a) and (c).  In re              
          Baxter Travenol Labs., 952 F.2d 388, 391, 21 USPQ2d 1281, 1285              
          (Fed. Cir. 1991) (“It is not the function of this court to                  
          examine the claims in greater detail than argued by an appellant,           
          looking for nonobvious distinctions over the prior art.”); In re            
          Wiechert, 370 F.2d 927, 936, 152 USPQ 247, 254 (CCPA 1967) (“This           
          court has uniformly followed the sound rule that an issue raised            
          below which is not argued in that court, even if it has been                
          properly brought here by a reason of appeal, is regarded as                 
          abandoned and will not be considered.  It is our function as a              
          court to decide disputed issues, not to create them.”).                     
               At the outset, we note the grouping elected by appellant               
          (see brief at pages 10 and 11):                                             
               Group I:   claims 1, 7, 10, 30-35 and 40-45.                           
               Group II:  claims 5, 16, and 39.                                       
               Group III: claims 18, and 27-29.                                       
               We note that there are many combinations of the different              
          references used by the examiner to reject the various claims,               
          however, we will analyze the claims according to the grouping               
          above.                                                                      



                                          6                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007